NHS genomics testing will be vital in supporting personalised cancer trials [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
A panel at the NHS Confed Expo 2024, held at the Manchester Central Convention Centre, heard from key players in the UK's oncology research space about how the latest innovations will intertwine to support and bolster research. Peter Johnson, national clinical director for cancer of NHS England said that the genomic medicine programme will help speed up the development time for these therapies. “Genome diagnostics will guide us to both understanding prognosis and understanding the most effective forms of treatment,” Johnson said. “As a result, it will directly allow us to develop some of these vaccine strategies, which is something that we need to progress as rapidly as possible.” Professor Dame Sue Hill, chief scientific officer for NHS England and head of NHS Genomic Medicine Centres, spoke about how the genomics programme supports drug development, specifically in oncology. “We funded an infrastructure to support innovation, and alignment with research and development an
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- COVID summer wave grows, especially in West, with new variant LB.1 on the rise [CBS News]CBS News
- Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine propaganda [Yahoo! Finance]Yahoo! Finance
- Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine propaganda [Los Angeles Times (CA)]Los Angeles Times
- How (And Why) Bird Flu Is About To Enter The "Mass Testing" Phase [zero hedge]zero hedge
- Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 6/21/24 - Form 4
- 6/18/24 - Form 144
- 6/18/24 - Form 4
- MRNA's page on the SEC website